Policy

Here we go again: Monkeypox challenges echo the early days of COVID-19
Here we go again: Monkeypox challenges echo the early days of COVID-19
Lecia Bushak
August 5, 2022
11:35 am

Over the past two months, the country has experienced all-too-familiar issues around testing, vaccine distribution and communication.

As opioid epidemic rages, Biden policy inches toward harm-reduction
As opioid epidemic rages, Biden policy inches toward harm-reduction
Lecia Bushak
July 28, 2022
5:27 pm

The administration has begun to incorporate harm-reduction language in its approach to drug control, which represents a major shift in U.S. policy.

Moves to protect abortion, contraception access may fall short
Moves to protect abortion, contraception access may fall short
Lecia Bushak
July 22, 2022
10:45 am

Executive order or no, abortion and contraception advocates fear that action has been too little, too late.

Congress turns its attention to drug pricing regulation. Again.
Congress turns its attention to drug pricing regulation. Again.
Lecia Bushak
July 14, 2022
3:14 pm

After the most recent pricing proposal died last year with the Build Back Better bill, lawmakers are aiming to revive it.

HHS moves to maintain access for medication abortion
HHS moves to maintain access for medication abortion
Lecia Bushak
June 30, 2022
11:54 am

Agency Secretary Xavier Becerra characterized increasing access as “a national imperative.”

ARPA-H is officially established. Now what?
ARPA-H is officially established. Now what?
Lecia Bushak
June 6, 2022
12:23 pm

Biden’s new life sciences agency faces questions over funding, scope and more.

Senate unveils user fee reauthorization draft, leaves out accelerated approval reform
Senate unveils user fee reauthorization draft, leaves out accelerated approval reform
Lecia Bushak
May 19, 2022
2:59 pm

User fees have historically been used to bolster the FDA’s work in reviewing the safety and efficacy of drugs, and must be renewed every five years.

The public health infrastructure debacle, revisited
The public health infrastructure debacle, revisited
Lecia Bushak
May 12, 2022
2:59 pm

As Congress struggles to secure more pandemic aid, experts are once again calling for long-term investment in public health infrastructure. Will anyone listen?

Inside the FDA/McKinsey divorce
Inside the FDA/McKinsey divorce
Lecia Bushak
May 5, 2022
1:00 pm

The agency is severing ties with McKinsey in the wake of conflict-of-interest concerns around the consultancy’s work with opioid makers.

Can the CDC’s internal review staunch the credibility and comms bleeding?
Can the CDC’s internal review staunch the credibility and comms bleeding?
Lecia Bushak
April 7, 2022
11:23 am

The agency has acknowledged that it has a problem. Now comes the hard part.

  • From Our Partners